Subject: Medicine

Press Releases

Mentice at EuroPCR, Paris

May 10, 2012 08:28 EDT Mentice AB EuroPCR is the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions. May 15-18

May 07, 2012 02:00 EDT Viropharma ViroPharma Incorporated (NASDAQ: VPHM) today announced that three posters relating to long term data on Plenadren® (hydrocortisone, modified release tablet) were presented at the 2012 joint 15th International Congress of Endocrinology and 14th European Congress of Endocrinology (ICE/ECE), held May 5 through 9, in Florence, Italy.

Carbon monoxide why experts are a must.

Feb 14, 2012 04:06 EST www.carbonmonoxidekills.com In the event that you have suffered damage after a carbon monoxide exposure if you don't get the experts involved it could jeopardise your future. You will need to take control and not get pulled along by the tide of inept professionals.

Dec 01, 2011 11:15 EST Halo Genomics Uppsala, Sweden, December 1, 2011 – Halo Genomics today announced it has been acquired by Agilent Technologies Inc. (NYSE: A), the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications.

Nov 22, 2011 03:00 EST Halo Genomics Halo Genomics AB, a company providing products for next generation targeted sequencing, today announced the appointment of D-MARK Biosciences as its distributor in Canada.

Olink AB and Bethyl sign distribution agreement for the US market

Nov 21, 2011 09:00 EST Olink Bioscience Olink Bioscience, a Sweden based biotechnology company focused on innovative protein detection technologies, has entered into a distribution agreement with Bethyl Laboratories, Inc. Together with Bethyl Olink Bioscience will continue to expand the distribution of the Duolink® product line in the US market.

Nov 18, 2011 03:25 EST dPCom A/S dPCom A/S, producer of Sensometrics Technology, is pleased to announce the results of a recent clinical trial at the Oslo University Hospital – Rikshospitalet which indicate that patients with intracranial aneurysm bleeds treated with Sensometrics Technology were more than three times as likely to recover completely as compared to patients treated with traditional methods.

Nov 15, 2011 08:00 EST Viropharma ViroPharma Incorporated (NASDAQ: VPHM) today announced that it completed its acquisition of DuoCort Pharma AB. The acquisition further expands ViroPharma’s orphan disease commercial product pipeline. ViroPharma has paid an upfront closing cost of 220 million Swedish kroner (SEK) or $33.6 million in US dollars (USD). Additionally, there are contingent milestone payments of up to 860 million SEK.

Halo Genomics partner in € 40 million European epigenomics research project

Nov 10, 2011 04:00 EST Halo Genomics UPPSALA, Sweden, November 10, 2011 – Halo Genomics AB, a company providing products for next generation targeted resequencing, will develop HaloPlex PCR technology for large scale methylation analysis

DuoCort Pharma’s Orphan Drug Plenadren® Granted European Marketing Authorization for Adrenal Insufficiency

Nov 07, 2011 07:00 EST Viropharma The Swedish specialty pharma company, DuoCort Pharma, announced today that the European Commission has granted a European Marketing Authorisation for Plenadren® (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults, bringing these patients their first pharmaceutical innovation in over 50 years.